AGC expands Spanish site
AGC has announced plans to expand its CDMO subsidiary, AGC Pharma Chemicals Europe. As well as adding 30% to the capacity of its production facilities by May 2022, this will see the addition of a new micronisation facility and a new R&D facility, which is due to begin operation in March 2021. The plant, near Barcelona, was originally known as Malgrat Pharma Chemicals.
AGC acquired from Boehringer Ingelheim in March 2019 to establish a synthetic pharmaceutical production capability in Europe. It supplies both APIs and intermediates. The additional amount being invested now was not disclosed.